Citation

Heather Ribaudo, Ph.D., Daniel R. Kuritzkes, M.D., Roy (Trip) Gulick, M.D., M.P.H. A comparison of three initial antiretroviral AIDS regimens. New England Journal of Medicine. 2007 Sep 06; 357(10):1056-7.

Citation

Scott Evans, Ph.D. When and how can endpoints be changed after initiation of a randomized clinical trial?. Public Library of Science Clinical Trials. 2007 Apr 13; 2(4):e18.

Citation

Brian Wells Pence, Ph.D., Susan Reif, Ph.D., M.S.W, Kathryn Whetten, Ph.D., M.P.H., Jane Leserman, Ph.D., Dalene Stangl, Ph.D., Marvin Swartz, M.D., Nathan Thielman, M.D., M.P.H., Michael J. Mugavero, M.D., M.H.S. Minorities, the poor and survivors of abuse: HIV-infected patients in the US deep south. Journal of the Southern Medical Association. 2007 Nov 01; 100(11):1114-22.

Citation

Susan C. Morpeth, MB ChB, DTM&H, John A. Crump, MB ChB, DTM&H, Humphrey J. Shao, M.D., Habib O. Ramadhani, M.D., Peter R. Kisenge, M.D., MMED, Cindy A. Moylan, Susanna Naggie, L. Brett Caram, Keren Z. Landman, Noel E. Sam, Dafrosa K. Itemba, B.A., John F. Shao, M.D., Ph.D., John Alexander Bartlett, M.D., Nathan Thielman, M.D., M.P.H. Predicting CD4 lymphocyte count <200 cells/mm3 in an HIV type 1-infected African population. AIDS Research and Human Retroviruses. 2007 Oct 01; 23(10):1230-6.

Citation

Giovanni Schifitto, M.D., Bradford A. Navia, M.D., Constantin Yiannoutsos, Ph.D., Christina M. Marra, M.D., Linda Chang, M.D., Thomas Ernst, Ph.D., Jeffrey G. Jarvik, M.D., M.P.H., Eric N. Miller, Ph.D., Elyse J. Singer, M.D., Ronald J. Ellis, M.D.,Ph.D., Dennis Kolson, M.D., Ph.D., David M. Simpson, M.D., Avindra Nath, M.D., Joseph R. Berger, M.D., Sharon L. Shriver, R.Ph., M.S., Linda L. Millar, B.S., Dodi Colquhoun, M.Sc., Robert Lenkinski, Ph.D., R.Gilberto Gonzalez, M.D., Ph.D., Stuart A. Lipton, M.D., Ph.D. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS. 2007 Sep 01; 21(14):1877-86.

Citation

Richard H. Haubrich, M.D., Hongyu Jiang, Ph.D., Ronald Swanstrom, Ph.D., Michael P. Bates, M.D., David Katzenstein, M.D., Leslie A. Petch, Ph.D., Courtney V. Fletcher, Pharm.D., Susan A. Fiscus, Ph.D., Roy (Trip) Gulick, M.D., M.P.H. Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359. HIV Clinical Trials. 2007 Mar 15; 8(2):63-7.

Citation

Jack T. Stapleton, M.D., Kara Bennett, M.S., Ronald J. Bosch, Ph.D., Philip M. Polgreen, Susan Swindells, M.B.B.S. Effect of antiretroviral therapy and hepatitis C co-infection on changes in lipid levels in HIV-infected patients 48 weeks after initiation of therapy. HIV Clinical Trials. 2007 Nov 01; 8(6):429-36.

Citation

Smita A. Kshirsagar, Terrence F. Blaschke, M.D., Lewis Sheiner, M.D., Mizue Krygowski, B.A., Edward P. Acosta, Pharm.D., Davide Verotta, Ph.D. Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria. Journal of Pharmacokinetics & Pharmacodynamics (prev. Journal of Pharmacokinetics and Biopharmaceutics). 2007 Feb 01; 34(1):35-55.